Pharmaceutical stocks, particularly Indian firms, plummeted following President Trump's announcement of 100% tariffs on imported branded medicines to

Sen. Cassidy questions Trump administration’s link of Tylenol to autism; Trump’s autism research source was deemed “unreliable”; Measles cases top 1,500 domestically.

Indian markets opened lower as Sensex fell over 300 points and Nifty slipped below 24,850, with pharma stocks like Sun Pharma and Dr. Reddy’s dropping up to 4% after US tariff announcement.

The pharmaceutical industry has immense pressure to deliver advanced and novel therapies to patients worldwide but faces monumental challenges in drug development. On average, the journey from discovery of a compound to a marketed product spans over a ...